Pioglitazone after ischemic stroke

作     者：Kernan WN Viscoli CM Furie KL 

出 版 物：《中华物理医学与康复杂志》 (Chinese Journal of Physical Medicine and Rehabilitation)

年 卷 期：2016年第38卷第9期

页      面：716-716页

核心收录：

学科分类：0710[理学-生物学] 081704[工学-应用化学] 07[理学] 08[工学] 0817[工学-化学工程与技术] 071009[理学-细胞生物学] 09[农学] 070303[理学-有机化学] 0901[农学-作物学] 0703[理学-化学] 090102[农学-作物遗传育种] 

主　　题：吡格列酮 脑缺血 2型糖尿病 中风 胰岛素抵抗 心肌梗死 激动剂 心血管 

摘      要：BACKGROUND AND OBJECTIVE As insulin resistance is present in more than 50%of patients without diabetes who have had an ischemic stroke or TIA,addressing this issue seems central to the treatment of these *** one medication,pioglitazone,a peroxisome proliferator-activated receptor y agonist,has been found to reduce the risk of cardiovascular events in patients with type 2 diabetes,this